Who can get the survival benefit of primary tumor resection for de novo stage IV breast cancer?
Ann Palliat Med
.
2022 Jun;11(6):2184-2185.
doi: 10.21037/apm-22-569.
Epub 2022 Jun 6.
Author
Tadahiko Shien
1
Affiliation
1
Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
PMID:
35695052
DOI:
10.21037/apm-22-569
No abstract available
Publication types
Editorial
MeSH terms
Breast Neoplasms* / pathology
Disease-Free Survival
Female
Humans
Neoplasm Staging
Retrospective Studies
Survival Rate